Joseph Todisco

Insider Reports History

Reporting-owner location: Bridgewater, NJ
Latest reporting-owner signature: /s/ Joseph Todisco
Source: Latest parsed Forms 3/4/5 signature
Transaction source note: Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Joseph Todisco

Form 4 holding Chief Executive Officer, Director

CorMedix Inc.

Security class: Common Stock
Shares / value: 774,749
Estimated value: $5,469,727
Report date: 04 Feb 2026
Price: $7.06
Ownership: Direct

Form 4 holding Executive Vice President

Amneal Pharmaceuticals, Inc.

Security class: Class A Common Stock
Shares / value: 327,194
Estimated value: $1,350,231
Report date: 07 May 2022
Price: $4.13
Ownership: Direct

Form 4 holding Director

TALPHERA, INC.

Security class: Common Stock
Shares / value: 11,497
Estimated value: $8,587
Report date: 22 Jun 2026
Price: $0.7469
Ownership: Direct

Form 4 holding Chief Executive Officer, Director

CorMedix Inc.

Security class: Stock Option (Right to Buy Common Stock)
Shares / value: 411,245
Estimated value
Report date: 16 Jan 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Director

TALPHERA, INC.

Security class: Director Stock Option (right to buy)
Shares / value: 30,700
Estimated value
Report date: 22 Jun 2026
Price
Ownership: Direct
Underlying class: Common Stock
Underlying amount

Form 4 holding Executive Vice President

Amneal Pharmaceuticals, Inc.

Security class: Restricted Stock Units
Shares / value: 0
Estimated value
Report date: 07 May 2022
Price
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount

Insider Reports Filed by Joseph Todisco

4 TLPH

TALPHERA, INC.

Report period: 22 Jun 2026
Transactions: 2
Transaction value: $0
Accepted by SEC: 24 Jun 2026, 17:14
Role: Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 04 Feb 2026
Transactions: 1
Transaction value: $0
Accepted by SEC: 06 Feb 2026, 21:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 23 Jan 2026
Transactions: 2
Transaction value: -$198,515
Accepted by SEC: 27 Jan 2026, 21:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 12 Jan 2026
Transactions: 4
Transaction value: -$178,203
Accepted by SEC: 20 Jan 2026, 09:28
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 18 Dec 2025
Transactions: 3
Transaction value: -$227,100
Accepted by SEC: 19 Dec 2025, 21:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 TLPH

TALPHERA, INC.

Report period: 15 Oct 2025
Transactions: 2
Transaction value: $0
Accepted by SEC: 16 Oct 2025, 18:49
Role: Director
Next action: Open filing details

3 TLPH

TALPHERA, INC.

Report period: 14 Oct 2025
Transactions: 0
Transaction value: $0
Accepted by SEC: 16 Oct 2025, 18:47
Role: Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 12 Sep 2025
Transactions: 3
Transaction value: -$476,500
Accepted by SEC: 12 Sep 2025, 21:45
Role: Chief Executive Officer
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 10 May 2025
Transactions: 1
Transaction value: -$247,484
Accepted by SEC: 12 Sep 2025, 21:31
Role: Chief Executive Officer
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 01 Apr 2025
Transactions: 2
Transaction value: +$199,995
Accepted by SEC: 02 Apr 2025, 07:00
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 17 Jan 2025
Transactions: 2
Transaction value: -$291,800
Accepted by SEC: 22 Jan 2025, 21:11
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 10 Jan 2025
Transactions: 1
Transaction value: -$199,507
Accepted by SEC: 14 Jan 2025, 19:16
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 10 May 2024
Transactions: 1
Transaction value: -$139,497
Accepted by SEC: 13 May 2024, 16:22
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 13 Mar 2024
Transactions: 1
Transaction value: +$50,718
Accepted by SEC: 14 Mar 2024, 08:45
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 12 Jan 2024
Transactions: 3
Transaction value: -$47,820
Accepted by SEC: 17 Jan 2024, 20:04
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 08 Sep 2023
Transactions: 1
Transaction value: +$37,100
Accepted by SEC: 08 Sep 2023, 16:21
Role: Chief Executive Officer, Director
Next action: Open filing details

4/A CRMD

CorMedix Inc.

Report period: 17 May 2023
Transactions: 1
Transaction value: +$22,900
Accepted by SEC: 18 May 2023, 16:49
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 10 May 2023
Transactions: 1
Transaction value: -$198,448
Accepted by SEC: 12 May 2023, 18:16
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 14 Jan 2023
Transactions: 1
Transaction value: $0
Accepted by SEC: 18 Jan 2023, 18:04
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 15 Nov 2022
Transactions: 1
Transaction value: +$76,400
Accepted by SEC: 16 Nov 2022, 15:56
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 24 Aug 2022
Transactions: 1
Transaction value: +$18,424
Accepted by SEC: 25 Aug 2022, 08:37
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 16 May 2022
Transactions: 1
Transaction value: +$33,800
Accepted by SEC: 17 May 2022, 08:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 CRMD

CorMedix Inc.

Report period: 10 May 2022
Transactions: 2
Transaction value: $0
Accepted by SEC: 12 May 2022, 16:30
Role: Chief Executive Officer, Director
Next action: Open filing details

4 AMRX

Amneal Pharmaceuticals, Inc.

Report period: 07 May 2022
Transactions: 3
Transaction value: -$5,311
Accepted by SEC: 10 May 2022, 18:58
Role: Executive Vice President
Next action: Open filing details

3 CRMD

CorMedix Inc.

Report period: 18 Mar 2022
Transactions: 0
Transaction value: $0
Accepted by SEC: 22 Mar 2022, 16:11
Role: Director
Next action: Open filing details

4 AMRX

Amneal Pharmaceuticals, Inc.

Report period: 01 Mar 2022
Transactions: 8
Transaction value: -$58,905
Accepted by SEC: 03 Mar 2022, 20:22
Role: Executive Vice President
Next action: Open filing details

4 AMRX

Amneal Pharmaceuticals, Inc.

Report period: 27 Feb 2022
Transactions: 3
Transaction value: -$50,981
Accepted by SEC: 01 Mar 2022, 16:12
Role: Executive Vice President
Next action: Open filing details

4 AMRX

Amneal Pharmaceuticals, Inc.

Report period: 02 Dec 2021
Transactions: 1
Transaction value: -$6,150
Accepted by SEC: 03 Dec 2021, 17:19
Role: Executive Vice President
Next action: Open filing details

4 AMRX

Amneal Pharmaceuticals, Inc.

Report period: 07 May 2021
Transactions: 3
Transaction value: -$8,122
Accepted by SEC: 11 May 2021, 14:56
Role: Executive Vice President
Next action: Open filing details

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .